Annual Net Income
-$75.37 M
-$16.38 M-27.78%
September 30, 2024
Summary
- As of February 7, 2025, OTLK annual net profit is -$75.37 million, with the most recent change of -$16.38 million (-27.78%) on September 30, 2024.
- During the last 3 years, OTLK annual net income has fallen by -$22.20 million (-41.76%).
- OTLK annual net income is now -448.82% below its all-time high of -$13.73 million, reached on September 30, 2014.
Performance
OTLK Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
$5.69 M
-$38.72 M-87.18%
September 1, 2024
Summary
- As of February 7, 2025, OTLK quarterly net profit is $5.69 million, with the most recent change of -$38.72 million (-87.18%) on September 1, 2024.
- Over the past year, OTLK quarterly net income has increased by +$16.87 million (+150.91%).
- OTLK quarterly net income is now -87.18% below its all-time high of $44.41 million, reached on June 30, 2024.
Performance
OTLK Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$75.37 M
+$18.68 M+19.86%
September 1, 2024
Summary
- As of February 7, 2025, OTLK TTM net profit is -$75.37 million, with the most recent change of +$18.68 million (+19.86%) on September 1, 2024.
- Over the past year, OTLK TTM net income has dropped by -$23.87 million (-46.35%).
- OTLK TTM net income is now -1435.81% below its all-time high of -$4.91 million, reached on December 31, 2014.
Performance
OTLK TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
OTLK Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -27.8% | +150.9% | -46.4% |
| 3 y3 years | -41.8% | +142.5% | -41.8% |
| 5 y5 years | -118.3% | +199.8% | -104.6% |
OTLK Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -41.8% | at low | -87.2% | +105.0% | -46.4% | +52.6% |
| 5 y | 5-year | -118.3% | at low | -87.2% | +105.0% | -127.8% | +52.6% |
| alltime | all time | -448.8% | at low | -87.2% | +105.0% | -1435.8% | +52.6% |
Outlook Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | -$75.37 M(+27.8%) | - | - |
| Sep 2024 | - | $5.69 M(-87.2%) | -$75.37 M(-19.9%) |
| Jun 2024 | - | $44.41 M(-138.9%) | -$94.05 M(-40.9%) |
| Mar 2024 | - | -$114.29 M(+922.4%) | -$159.13 M(+209.0%) |
| Dec 2023 | - | -$11.18 M(-14.0%) | -$51.50 M(-12.7%) |
| Sep 2023 | -$58.98 M(-10.7%) | -$12.99 M(-37.2%) | -$58.98 M(-2.2%) |
| Jun 2023 | - | -$20.68 M(+210.7%) | -$60.34 M(+5.5%) |
| Mar 2023 | - | -$6.65 M(-64.3%) | -$57.20 M(-18.6%) |
| Dec 2022 | - | -$18.66 M(+30.1%) | -$70.25 M(+6.4%) |
| Sep 2022 | -$66.05 M(+24.2%) | -$14.35 M(-18.2%) | -$66.05 M(+1.4%) |
| Jun 2022 | - | -$17.54 M(-11.0%) | -$65.11 M(+8.9%) |
| Mar 2022 | - | -$19.70 M(+36.2%) | -$59.77 M(+12.4%) |
| Dec 2021 | - | -$14.46 M(+7.9%) | -$53.17 M(+0.0%) |
| Sep 2021 | -$53.16 M(+50.9%) | -$13.40 M(+9.9%) | -$53.16 M(+7.0%) |
| Jun 2021 | - | -$12.20 M(-6.9%) | -$49.68 M(+22.7%) |
| Mar 2021 | - | -$13.11 M(-9.3%) | -$40.50 M(+22.4%) |
| Dec 2020 | - | -$14.46 M(+45.7%) | -$33.09 M(-6.1%) |
| Sep 2020 | -$35.24 M(+2.1%) | -$9.92 M(+229.1%) | -$35.24 M(-0.5%) |
| Jun 2020 | - | -$3.01 M(-47.1%) | -$35.41 M(-3.9%) |
| Mar 2020 | - | -$5.70 M(-65.7%) | -$36.84 M(-11.0%) |
| Dec 2019 | - | -$16.60 M(+64.4%) | -$41.38 M(+19.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | -$34.52 M(+14.7%) | -$10.10 M(+127.3%) | -$34.52 M(-5.7%) |
| Jun 2019 | - | -$4.44 M(-56.7%) | -$36.63 M(-9.8%) |
| Mar 2019 | - | -$10.24 M(+5.2%) | -$40.62 M(+7.1%) |
| Dec 2018 | - | -$9.74 M(-20.1%) | -$37.91 M(+26.0%) |
| Sep 2018 | -$30.09 M(-22.5%) | -$12.20 M(+44.7%) | -$30.09 M(+24.0%) |
| Jun 2018 | - | -$8.43 M(+11.8%) | -$24.27 M(+14.6%) |
| Mar 2018 | - | -$7.54 M(+292.6%) | -$21.17 M(-2.3%) |
| Dec 2017 | - | -$1.92 M(-69.9%) | -$21.67 M(-44.2%) |
| Sep 2017 | -$38.85 M(-27.1%) | -$6.37 M(+19.5%) | -$38.85 M(-9.7%) |
| Jun 2017 | - | -$5.33 M(-33.7%) | -$43.04 M(-28.3%) |
| Mar 2017 | - | -$8.05 M(-57.9%) | -$60.04 M(+8.1%) |
| Dec 2016 | - | -$19.10 M(+80.7%) | -$55.54 M(+4.2%) |
| Sep 2016 | -$53.30 M(+12.5%) | -$10.57 M(-52.7%) | -$53.30 M(-11.0%) |
| Jun 2016 | - | -$22.33 M(+530.3%) | -$59.90 M(+22.5%) |
| Mar 2016 | - | -$3.54 M(-79.0%) | -$48.91 M(-17.6%) |
| Dec 2015 | - | -$16.86 M(-1.7%) | -$59.35 M(+25.2%) |
| Sep 2015 | -$47.39 M(+245.1%) | -$17.16 M(+51.4%) | -$47.39 M(+56.8%) |
| Jun 2015 | - | -$11.34 M(-18.9%) | -$30.23 M(+60.0%) |
| Mar 2015 | - | -$13.98 M(+184.9%) | -$18.89 M(+284.9%) |
| Dec 2014 | - | -$4.91 M | -$4.91 M |
| Sep 2014 | -$13.73 M | - | - |
FAQ
- What is Outlook Therapeutics annual net profit?
- What is the all time high annual net income for Outlook Therapeutics?
- What is Outlook Therapeutics annual net income year-on-year change?
- What is Outlook Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Outlook Therapeutics?
- What is Outlook Therapeutics quarterly net income year-on-year change?
- What is Outlook Therapeutics TTM net profit?
- What is the all time high TTM net income for Outlook Therapeutics?
- What is Outlook Therapeutics TTM net income year-on-year change?
What is Outlook Therapeutics annual net profit?
The current annual net income of OTLK is -$75.37 M
What is the all time high annual net income for Outlook Therapeutics?
Outlook Therapeutics all-time high annual net profit is -$13.73 M
What is Outlook Therapeutics annual net income year-on-year change?
Over the past year, OTLK annual net profit has changed by -$16.38 M (-27.78%)
What is Outlook Therapeutics quarterly net profit?
The current quarterly net income of OTLK is $5.69 M
What is the all time high quarterly net income for Outlook Therapeutics?
Outlook Therapeutics all-time high quarterly net profit is $44.41 M
What is Outlook Therapeutics quarterly net income year-on-year change?
Over the past year, OTLK quarterly net profit has changed by +$16.87 M (+150.91%)
What is Outlook Therapeutics TTM net profit?
The current TTM net income of OTLK is -$75.37 M
What is the all time high TTM net income for Outlook Therapeutics?
Outlook Therapeutics all-time high TTM net profit is -$4.91 M
What is Outlook Therapeutics TTM net income year-on-year change?
Over the past year, OTLK TTM net profit has changed by -$23.87 M (-46.35%)